Vireo Growth Inc.

C$9.20As of Sun 8 Nov 2026, 12:00 UTC
CSE:VREOHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (32.00%)
Div yield —
ROE (18.88%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM —
TSR TTM (64.75%)
Mkt cap C$481.3M
ROIC 5.04%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
20.68%
(55.37%)
Hold 11|10|11|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.12
0.11
0.13
17.61%
13.28%
6.02%
14.27%
Revenue$M
60.79
63.75
67.21
68.70
1.91%
9.70%
12.28%
15.28%
Peers (US$342.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.136
0.137
0.129
EBIT/Intx
2.528
0.108
0.121
Own earn%
(8.70)
(11.13)
(26.75)
Sh yield%
20.70
28.95
33.49
Owners
Insiders/Inst%
4.46
70.67
Short interest%
3.25
SBC / revenue%
3.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–7
$1 testx
—
Incr. ROIC%
4